- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Deaths Tied to ‘Fake Xanax’ Street Drug Are Soaring
Three twenty-somethings in Chicago took a street drug they thought was a harmless form of Xanax.
All three were found collapsed and unresponsive eight hours later by one of their mothers, who had them rushed to the hospital.
After multiple seizures, fever and heart damage, all three are thought to have recovered, but not before spending many days hospitalized.
According to a new report, the drug they actually took was an unapproved benzodiazepine sedative called bromazolam, with street names like “Fake Xanax” and “Dope.”
It’s increasingly being distributed illicitly online or on the street and, when mixed with fentanyl, is also fueling a rising number of deaths.
Law enforcement drug seizures in the United States involving bromazolam have soared from only a handful in 2018 to more than 2,900 by 2023, according to researchers led by Dr. Paul Ehlers, a toxicologist at Cook County Hospital in Chicago.
“In Illinois, bromazolam-involved deaths increased from 10 in 2021 to 51 in 2022,” a five-fold increase in just one year, the team noted.
Bromazolam is showing up in other states, too.
“It’s a very powerful drug, and when you mix a drug like that and mix it with fentanyl and some of the other opiates, it’s just a recipe for disaster,” Hamilton County Coroner Jeff Jellison told Indiana’s Fox59 News in December.
In a Facebook post, he said signs of dangerous bromazolam use can include “loss of coordination, dizziness, drowsiness, blurred vision, slurred speech, muscle relaxation, difficulty breathing, amnesia and death.”
The three cases noted in the Chicago report occurred early in 2023 and, luckily, fentanyl was not involved. All three young people experienced multiple, recurrent seizures and required tubes while in the ICU to help maintain breathing. All showed evidence of heart damage caused by their experience.
Two of the patients, both males aged 25, recovered and were discharged after four days and 11 days of hospital care.
The youngest patient, a 20-year-old woman, developed a form of epilepsy and fell into a coma. After 11 days in one hospital she was transferred to another hospital, after which her history is unknown, Ehler’s group said.
The report also notes that bromazolam is increasingly showing up in DUI cases, because of its sedating effect on drivers.
Ehler’s team are alerting doctors, EMS crews and health officials to be on the lookout for overdoses involving bromazolam, especially when seizures and fever are present.
The report was published in the Jan. 5 issue of Morbidity and Mortality Weekly Report, a journal of the U.S. Centers for Disease Control and Prevention.
More information
Find out more about bromazolam at the National Association of Drug Diversion Investigators.
SOURCE: Morbidity and Mortality Weekly Report, Jan. 5, 2023
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.